GLC vs BRG for RX?

Dealing with offers from both, how are both's reputation in the greater RX scene? Top tier or not? Which has more brand "recognition" and sets me up better for exits? Especially with GLC, not a lot of info regarding it?

22 Comments
 
Most Helpful

received offers from both of these, assuming you mean for SA.

GLC is much more boutique on the IB scene, while BRG is more known in the consulting scene, being probably the 4th biggest player in rxco.

 If you want traditional finance exits GLC is the way to go, there are people going from GLC to very good credit/distressed exits. rxco is more seen as the exit and you will see less people leaving the scene to do other things compared to rxib.

Would say that you will have an easier time going from rxib to rxco if you want, BRG does hire ex bankers(even coverage) while there is a shocking lack of people going from rxco to rxib.

 

 

I'm worried about not many people knowing about GLC, like I've gotten some raised eyebrows when mentioning the name, from people in finance. Will I end up in a situation where that'll be a problem? 

Going off BRG being arguably the 4th biggest in the scene, hypothetically what exits would that open up to me, since I assume you did plenty of research on this as well before making your choice. Notwithstanding it being an "exit" career.

 

Got a much more brand name rx ib offer so took that instead. your rx co exits will be similar, mostly PC/distressed PE, but imo being in rxib is an easier translation to financial exits. Rxco to me is more of a long term thing where you want to aim for CRO/CFO roles

 

Funny enough, also received offers from both firms while going through SA recruiting process. Was interested in RX and wanted to land a spot in NYC. Ended up taking an offer with a MM IB in a traditional M&A coverage seat. The first user gave a very accurate description of the differences, but, going back to my thought process before the third offer came along, I would suggest GLC at the end of the day purely based off of exits. You’ll get your traditional investing exits from a spot in traditional RXIB vs RXCO, which would corner you more into the Operations and FP&A space, which can definitely still be lucrative and intellectually interesting (PE Ops partner, for example). While I agree that the BRG “brand name” is much more prevalent (as, in my opinion, the undisputed 4th best name in the RXCO space) I would still suggest someone so young in their career go with what will provide a larger array of exits, and that would be GLC imo, although I have seen a few BRG 1st and 2nd years land MM RX IB offers.

 

Would agree with the others, BRG is undisputedly king when it comes to placements to C-Suite though, compared with GLC. Yes, exits to distressed PE / HF are possible from BRG, but it's slightly easier from GLC. If you decide to move up to a T1 RX consulting firm though, I'd say to take that over GLC

 

Bump, looking for more information on GLC. Have seen some forums saying conflicting things and would love an updated viewpoint from someone with more knowledge.

 

I can speak to GLC - the culture sucks, absolutely blows which is why there’s such massive turnover at the junior levels before the two year analyst program is over. 5 days a week in office, heavy facetime culture, public yelling at juniors in the bullpen. Also - you won’t leave until your seniors do. That said, you will get interviews from credit MFs and HFs and some PE firms (def not MF PE though). For culture -> BRG, for exits -> GLC

 

You’re posting in the IB forum and asking whether you should take the IB or Consulting offer? Wtf?

 

Seriously. Cannot recall a single time commenters have ever recommended the consulting offer in this forum, even if it was a genuinely solid comparison.

 

The kids posting in WSO these days don’t even use their brain to think anymore. IB vs consulting RX workstreams aren’t even the same, take IB if you want IB - case closed. Fk prestige

 

Necessitatibus nam rerum quibusdam. Ab fugit deserunt optio.

Quia libero eum et aspernatur possimus consequatur a. Est voluptatem voluptas et.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”